Global health care company Novartis recently announced it is launching innovation labs across the globe, including Silicon Valley. The project—Novartis Biome—will aim to spawn effective and precise new therapies at a time when technology, science, and big data are merging together.

Novartis Biome will begin in San Francisco, and include a partnership between Novartis and both Mekonos and Medable. Mekonos develops gene and cell therapies for cancer and other diseases, while Medable is a digital health firm that provides consumer-generated data for researchers, health startups, pharmaceuticals, and universities. Additionally, Novartis is partnering with companies in New York . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!